glp 1 agonists reduce inflammation Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits Current Insights, Advantages and Challenges
Description
Kwan EP, and Gaisano HY
doi: 10.4158/EP09104.CRR
showed that the activation of GLP-1R by liraglutide led to an anti-tumor effect on human pancreatic cancer via the inhibition of the PI3K/AKT pathway (224)
Kales Diabetes and Psychiatry Clinic, Visiting Diabetologist Mahaveer Hospital, Chhatrapati Sambhajinagar (Aurangabad)
The 8 and 12 mg groups shed the most weight but paid for it with the most stomach side effects, while the 4 mg group was easier to tolerate and still worked well
